Click to read the study in NEJM In-Depth [randomized controlled trial]: Provention Bios Type 1 Diabetes Trial Evaluating C-Peptide with Teplizumab (PROTECT) is a phase three, randomized, placebo-controlled trial that evaluated the efficacy of teplizumab in the preservation of -cell function in young patients with newly diagnosed type 1 diabetes
Glutathione works with Vitamin C, another antioxidant, helping to restore it to its active form after it has done its job
Exenatide (Byetta/Bydureon): Exenatide is an earlier-generation GLP-1 that is currently less expensive than semaglutide, but it needs to be administered more frequently and doesn't appear to have the same results in terms of weight loss and blood sugar control
BPC-157 Peptide Formulation Details BPC-157 Peptide Formulation Details This BPC-157 peptide for sale is supplied as a lyophilised powder the preferred format for maintaining peptide stability in research settings
Cheng MD, Nash TM, Kopetz ES
Reports of pancreatitis have surfaced in GLP-1 users, but its not clear if the drug is the culpritor if diabetes itself is to blame